多循环芳香致癌物对病毒复制的作用:与actinomycin D的相似性
Science (New York, N.Y.)
|October 30, 1964
概括
某些致癌碳化合物,如子烯,抑制DNA病毒复制,但不能抑制RNA病毒复制. 这表明这些化合物选择性地与病毒DNA相互作用,影响病毒生长.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 毒理学 毒理学 毒理学
背景情况:
- 致癌的多环碳化合物是已知的环境污染物.
- 一些碳化合物可以干扰细胞过程.
- 特定碳化合物的对病毒复制的影响尚未完全理解.
研究的目的:
- 研究致癌碳化合物的对DNA和RNA病毒复制的影响.
- 为了确定观察到的效应是否特定于DNA病毒.
- 探索这些碳化合物与病毒之间的相互作用机制.
主要方法:
- 将致癌碳化合物 ([a]烯,7,12-二甲基[a]烯) 纳入营养覆盖和病毒培养液体介质中.
- 对疹病毒,疫苗病毒 (DNA病毒) 和Sindbis病毒 (RNA病毒) 的斑块形成和病毒产量进行评估.
- 测试非致癌的多环碳化合物 ([e]pyrene, pyrene,[a]anthracene, anthracene) 以进行比较.
主要成果:
- 致癌的碳化合物抑制了斑块的形成,并降低了DNA病毒 (疹,疫苗) 的产量,但不是RNA病毒 (Sindbis).
- 非致癌类型的类似物没有影响病毒复制.
- 观察到的对病毒生长的影响类似于actinomycin D.
结论:
- 致癌的碳化合物可以选择性地抑制DNA病毒的复制.
- 这些发现表明,致癌性碳化合物与病毒DNA之间存在特定的相互作用.
- 该机制可能涉及干扰DNA依赖的过程,类似于actinomycin D.
相关概念视频
02:36DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...